Key Points
- IBM received a $1 billion federal grant to construct a quantum chip production facility in Albany, New York.
- The tech giant is contributing an additional $1 billion, establishing a new entity named Anderon for processor manufacturing.
- Shares of IBM surged 12% to reach $252.97 on Thursday, representing the company’s largest single-session increase in over twelve months.
- The Commerce Department’s $2 billion allocation encompasses more than nine firms, financed via the 2022 Chips and Science Act.
- Quantum computing competitors also experienced significant rallies: D-Wave soared 33%, Rigetti advanced 31%, and GlobalFoundries jumped 15%.
Shares of International Business Machines (IBM) surged 12% on Thursday following news that the federal government plans to grant the technology giant $1 billion for the construction of a quantum chip production facility.
International Business Machines Corporation, IBM
The stock finished trading at $252.97, recording its most substantial single-day percentage increase in more than twelve months.
This financial commitment represents a segment of a comprehensive $2 billion Commerce Department program focused on advancing the quantum computing industry. The funding originates from a research and development allocation that secured $11 billion through the 2022 Chips and Science Act.
IBM plans to match the federal contribution with $1 billion from its own resources. The combined capital will support the creation of Anderon, a newly established business unit dedicated to manufacturing quantum processors.
Construction will take place at an existing semiconductor research and manufacturing complex located in Albany, New York. Senator Chuck Schumer publicly acknowledged the funding award in a Thursday statement.
Under the arrangement, the federal government will acquire minority, noncontrolling ownership positions in each recipient company—a framework reflecting Commerce Secretary Howard Lutnick’s initiative to generate financial returns from Chips Act investments.
Quantum Sector Experiences Broad Rally
IBM’s stock performance was not an isolated occurrence. GlobalFoundries, which secured $375 million for developing specialized quantum computing chips, experienced a 15% price increase.
D-Wave Quantum posted a 33% gain, Rigetti Computing rose 31%, and Infleqtion jumped 31%. Each of these three companies executed letters of intent with the Commerce Department for potential awards reaching $100 million.
Atom Computing and Quantinuum were also designated to receive $100 million each. Emerging company Diraq is positioned to obtain $38 million.
Financial Framework Details
The $2 billion quantum initiative draws resources from an $11 billion research and development fund established within the larger $52 billion Chips Act. In the previous year, Lutnick reallocated $7.4 billion from this fund—capital that had been earmarked for a nonprofit organization—toward investment opportunities designed to deliver financial returns to the government.
The quantum computing program represents a continuation of this investment philosophy.
Final agreements have not yet been executed.
Based on GuruFocus analysis, IBM’s shares are currently valued at a 6.4% premium relative to the calculated fair value of $237.81. The corporation’s GF Score registers at 80 out of 100, featuring profitability metrics at 8/10 and valuation assessments at 9/10. Financial stability and price momentum indicators are comparatively lower at 5/10 and 4/10, respectively.
IBM’s price-to-earnings ratio stands at 22.37x, positioned beneath its five-year median level of 24.13x.
Over the most recent three-month period, company insiders executed net stock purchases totaling approximately $113,000, with zero insider selling activity documented.
